Nolpaza (Pantoprazole)

Pantoprazole, the active ingredient in Nolpaza, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is prescribed for conditions such as gastro‑oesophageal reflux disease, erosive oesophagitis, Zollinger‑Ellison syndrome and for preventing NSAID‑induced gastric ulcers.

GNH USA supplies Nolpaza as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Customers benefit from comprehensive technical support and on‑time delivery across multiple regions.

Pantoprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders. - Gastro‑oesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of the esophageal lining. - Erosive oesophagitis: facilitates ulcer healing by decreasing gastric acid exposure. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors. - Prevention of NSAID‑induced gastric ulcers: lowers ulcer risk in patients receiving non‑steroidal anti‑inflammatory drugs.

Pantoprazole may cause adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools, usually transient. - Nausea: feeling of stomach upset. - Abdominal pain: discomfort in the upper abdomen.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis with watery diarrhea. - Acute interstitial nephritis: kidney inflammation presenting with reduced urine output. - Stevens‑Johnson syndrome: rare skin reaction with blistering and mucosal involvement.

When prescribing Pantoprazole, clinicians should consider several precautionary measures to ensure safe use. - Assess renal function: dose adjustment may be required in severe impairment. - Monitor magnesium levels: prolonged therapy can lead to hypomagnesemia. - Evaluate for Helicobacter pylori infection: eradication therapy may be needed concurrently. - Use with caution in patients with liver disease: metabolism occurs hepatically. - Review concomitant medications: potential interactions with drugs requiring acidic pH for absorption. - Store at ambient temperature: keep below 25 °C, protect from moisture and keep in original packaging.

Pantoprazole can affect the pharmacokinetics of several medicines; interactions are grouped by clinical significance.

Major Interactions (Avoid): - Ketoconazole, itraconazole: reduced absorption due to increased gastric pH. - Atazanavir, nelfinavir: decreased plasma concentrations, compromising antiviral efficacy. - Clopidogrel: reduced activation leading to diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer monitoring. - Digoxin: higher serum levels may occur, watch for toxicity. - Methotrexate (high dose): decreased renal clearance, monitor renal function.